Gastrointestinal Diagnostics Market (By Test Type; By Technology; By Application; By Test Location) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Gastrointestinal Diagnostics Market 

5.1. COVID-19 Landscape: Gastrointestinal Diagnostics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Gastrointestinal Diagnostics Market, By Test Type

8.1. Gastrointestinal Diagnostics Market, by Test Type, 2022-2030

8.1.1. Endoscopy, Blood test

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. H. pylori test

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Calprotectin test

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Immunoglobulin A test

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Others

8.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Gastrointestinal Diagnostics Market, By Technology

9.1. Gastrointestinal Diagnostics Market, by Technology e, 2022-2030

9.1.1. PCR

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Microbiology

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. ELISA

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Others

9.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Gastrointestinal Diagnostics Market, By Application 

10.1. Gastrointestinal Diagnostics Market, by Application, 2022-2030

10.1.1. Infection

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Inflammatory Bowel Disease

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Gastroesophageal Reflux Disease (GERD)

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Cancer

10.1.4.1. Market Revenue and Forecast (2017-2030)

10.1.5. Others

10.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Gastrointestinal Diagnostics Market, By Test Location 

11.1. Gastrointestinal Diagnostics Market, by Test Location, 2022-2030

11.1.1. Central laboratories

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Point-of-Care

11.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Gastrointestinal Diagnostics Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Test Type (2017-2030)

12.1.2. Market Revenue and Forecast, by Technology (2017-2030)

12.1.3. Market Revenue and Forecast, by Application (2017-2030)

12.1.4. Market Revenue and Forecast, by Test Location (2017-2030)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Test Type (2017-2030)

12.1.5.2. Market Revenue and Forecast, by Technology (2017-2030)

12.1.5.3. Market Revenue and Forecast, by Application (2017-2030)

12.1.5.4. Market Revenue and Forecast, by Test Location (2017-2030)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Test Type (2017-2030)

12.1.6.2. Market Revenue and Forecast, by Technology (2017-2030)

12.1.6.3. Market Revenue and Forecast, by Application (2017-2030)

12.1.6.4. Market Revenue and Forecast, by Test Location (2017-2030)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Test Type (2017-2030)

12.2.2. Market Revenue and Forecast, by Technology (2017-2030)

12.2.3. Market Revenue and Forecast, by Application (2017-2030)

12.2.4. Market Revenue and Forecast, by Test Location (2017-2030)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Test Type (2017-2030)

12.2.5.2. Market Revenue and Forecast, by Technology (2017-2030)

12.2.5.3. Market Revenue and Forecast, by Application (2017-2030)

12.2.5.4. Market Revenue and Forecast, by Test Location (2017-2030)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Test Type (2017-2030)

12.2.6.2. Market Revenue and Forecast, by Technology (2017-2030)

12.2.6.3. Market Revenue and Forecast, by Application (2017-2030)

12.2.6.4. Market Revenue and Forecast, by Test Location (2017-2030)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Test Type (2017-2030)

12.2.7.2. Market Revenue and Forecast, by Technology (2017-2030)

12.2.7.3. Market Revenue and Forecast, by Application (2017-2030)

12.2.7.4. Market Revenue and Forecast, by Test Location (2017-2030)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Test Type (2017-2030)

12.2.8.2. Market Revenue and Forecast, by Technology (2017-2030)

12.2.8.3. Market Revenue and Forecast, by Application (2017-2030)

12.2.8.4. Market Revenue and Forecast, by Test Location (2017-2030)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Test Type (2017-2030)

12.3.2. Market Revenue and Forecast, by Technology (2017-2030)

12.3.3. Market Revenue and Forecast, by Application (2017-2030)

12.3.4. Market Revenue and Forecast, by Test Location (2017-2030)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Test Type (2017-2030)

12.3.5.2. Market Revenue and Forecast, by Technology (2017-2030)

12.3.5.3. Market Revenue and Forecast, by Application (2017-2030)

12.3.5.4. Market Revenue and Forecast, by Test Location (2017-2030)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Test Type (2017-2030)

12.3.6.2. Market Revenue and Forecast, by Technology (2017-2030)

12.3.6.3. Market Revenue and Forecast, by Application (2017-2030)

12.3.6.4. Market Revenue and Forecast, by Test Location (2017-2030)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Test Type (2017-2030)

12.3.7.2. Market Revenue and Forecast, by Technology (2017-2030)

12.3.7.3. Market Revenue and Forecast, by Application (2017-2030)

12.3.7.4. Market Revenue and Forecast, by Test Location (2017-2030)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Test Type (2017-2030)

12.3.8.2. Market Revenue and Forecast, by Technology (2017-2030)

12.3.8.3. Market Revenue and Forecast, by Application (2017-2030)

12.3.8.4. Market Revenue and Forecast, by Test Location (2017-2030)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Test Type (2017-2030)

12.4.2. Market Revenue and Forecast, by Technology (2017-2030)

12.4.3. Market Revenue and Forecast, by Application (2017-2030)

12.4.4. Market Revenue and Forecast, by Test Location (2017-2030)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Test Type (2017-2030)

12.4.5.2. Market Revenue and Forecast, by Technology (2017-2030)

12.4.5.3. Market Revenue and Forecast, by Application (2017-2030)

12.4.5.4. Market Revenue and Forecast, by Test Location (2017-2030)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Test Type (2017-2030)

12.4.6.2. Market Revenue and Forecast, by Technology (2017-2030)

12.4.6.3. Market Revenue and Forecast, by Application (2017-2030)

12.4.6.4. Market Revenue and Forecast, by Test Location (2017-2030)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Test Type (2017-2030)

12.4.7.2. Market Revenue and Forecast, by Technology (2017-2030)

12.4.7.3. Market Revenue and Forecast, by Application (2017-2030)

12.4.7.4. Market Revenue and Forecast, by Test Location (2017-2030)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Test Type (2017-2030)

12.4.8.2. Market Revenue and Forecast, by Technology (2017-2030)

12.4.8.3. Market Revenue and Forecast, by Application (2017-2030)

12.4.8.4. Market Revenue and Forecast, by Test Location (2017-2030)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Test Type (2017-2030)

12.5.2. Market Revenue and Forecast, by Technology (2017-2030)

12.5.3. Market Revenue and Forecast, by Application (2017-2030)

12.5.4. Market Revenue and Forecast, by Test Location (2017-2030)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Test Type (2017-2030)

12.5.5.2. Market Revenue and Forecast, by Technology (2017-2030)

12.5.5.3. Market Revenue and Forecast, by Application (2017-2030)

12.5.5.4. Market Revenue and Forecast, by Test Location (2017-2030)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Test Type (2017-2030)

12.5.6.2. Market Revenue and Forecast, by Technology (2017-2030)

12.5.6.3. Market Revenue and Forecast, by Application (2017-2030)

12.5.6.4. Market Revenue and Forecast, by Test Location (2017-2030)

Chapter 13. Company Profiles

13.1. BIOMERIEUX

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. F. Hoffmann-La Roche Ltd

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Abbott

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Beckman Coulter, Inc

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Siemens Healthineers AG

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. DiaSorin S.p.A

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. QIAGEN, Hologic, Inc

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Meridian Bioscience

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms